Amanda N. Raad

Partner

Amanda Raad, a U.S. lawyer who is also admitted as a Solicitor in England & Wales, serves as co-chair of Ropes & Gray’s award-winning global anti-corruption and international risk practice. Amanda has substantial experience negotiating with U.S. regulators on behalf of companies and individuals concerning cross-border matters involving corruption, money laundering, and other forms of financial fraud. These matters are often subject to scrutiny by foreign regulators given their multi-jurisdictional nature.

In addition, Amanda proactively works with clients across industries and geographies to identify and mitigate risk. This work includes advising private equity and other investor clients on risk-based diligence as well as effective and efficient portfolio company monitoring while preserving company independence.

Finally, Amanda advises clients on corporate social responsibility, supply chain compliance and responsible sourcing.

Amanda frequently publishes and speaks on cross-border challenges in the corporate crime and investigations space, including on sexual misconduct. She is a contributor to GIR’s “The Practitioner’s Guide to Global Investigations” and serves as a Director for Lawyers Without Borders, and a committee member for the Fraud Lawyers Association. Amanda is listed in GIR’s Women in Investigations 2018, Chambers UK, UK Legal 500, and New York Super Lawyers.

Experience

Defended international pharmaceutical and medical device companies in cross-border corruption investigations, resulting in favorable outcomes

Designed and implemented pre-acquisition international risk diligence protocols for multiple private equity firms and assisted with post-acquisition implementation of enhanced compliance controls

Led anti-corruption and international risk assessments in the private equity, pharmaceutical and energy sectors, resulting in the development and implementation of enhanced compliance controls

Counsel to several finance executives in international anti-money laundering and OFAC investigations

Counsel to senior executive in international criminal investigation of alleged collusion among banks in the setting of LIBOR and other benchmark interest rates

Participated in Lawyers Without Borders Kenya training of magistrates, prosecutors, and investigating officers of how to better investigate and prosecute wildlife crime

Partnered with Lawyers Without Borders to evaluate potential supply chain training opportunities to identify and mitigate human trafficking

Advised clients on the Modern Slavery Act and related obligations

Led a team representing inmates in New York City jails in a class action against the City of New York for guard brutality

Served as lead counsel in a political asylum case, presenting on behalf of the National Immigrant Justice Center, securing a positive outcome for the victim

Disclaimer

Publications

Global Investigations Review’s ‘Women in Investigations’, (2018)

Recognised as an ‘Up and Coming’ individual for ‘Financial Crime: Corporates’ in Chambers UK (2017)

New York Super Lawyers - Rising Stars (2014-2017)

UK Legal 500 (2014-2016)

Recipient - The Legal Aid Society, Society’s 2014 Pro Bono Publico Awards

Presentations

Publications

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The US Perspective,” The Practitioner’s Guide to Global Investigations, Third Edition (2019)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” The Practitioner’s Guide to Global Investigations, Third Edition (2019)

Quoted, “What Does a 'Bigger and Stronger' SFO Mean for Companies?,” The Anti-Corruption Report (November 28, 2018)

Quoted, “Behavioral Scientists Joining Risk Assessment Teams,” The Wall Street Journal (October 25, 2018)

Co-author, “Common Sense Prevails in the UK’s Battle over Legal Professional Privilege,” Expert Witness Journal (Autumn 2018)

Co-author, “Four Takeaways From the U.K.’s ENRC Privilege Decision,” The Anti-Corruption Report (October 17, 2018)

Quoted, “Real estate’s anti-corruption crusade,” PERE (September 2018)

Co-Author, “The DOJ’s Corporate Enforcement Policy: An upgraded Pilot Program,” The Practitioner’s Guide to Global Investigations (July 2018)

Quoted, “Beam Suntory Is the Latest Victim of the Beverages Industry in India,” The Anti-Corruption Report (July 25, 2018)

Quoted, “Can New SFO Chief Recharge Agency?,” The Wall Street Journal (June 5, 2018)

Co-author, “Compliance 2.0: The Role of Data and Behavioral Science in Risk Management,” The Anti-Corruption Report (May 16, 2018)

Co-author, “Creating a Successful Global Compliance Programme,” Pharmaceutical Market Europe (PME) magazine (May 9, 2018)

Participant, “Podcast - Risk Management: Troubleshooting & Problem Solving,” JD Supra (April 23, 2018)

Quoted, “Crafting and Delivering Effective Upjohn Warning,” The Anti-Corruption Report (April 18, 2018)

Author, “Risk Mitigation & Management: Bringing a Compliance Program to Life,” Lexology (April 11, 2018)

Co-author, “U.S. Legislation requires enhancements to modern slavery compliance procedures to address North Korean labour risks,” Trade Security Journal (March 2, 2018)

Quoted, “Best Practices for Fund Managers to Ensure a Fair Process When Disciplining Employees (Part Three of Three),” The Hedge Fund Law Report (February 22, 2018)

Quoted, “Best Practices for Fund Managers When Investigating and Documenting Employee Discipline (Part Two of Three),” The Hedge Fund Law Report (February 15, 2018)

Quoted, “Havens in hell: will EU tax evasion plans hit too hard?,” fDi magazine (February 15, 2018)

Quoted, “Best Practices for Fund Managers to Develop an Employee Discipline Framework That Fosters Predictability in the Face of Inconsistent Laws (Part One of Three),” The Hedge Fund Law Report (February 8, 2018)

Quoted, “High Court sides with RBS in litigation privilege dispute,” Global Investigations Review (February 6, 2018)

Quoted, “UK financial crime: NECC to launch; SFO director to quit,” StrategicRISK (January 24, 2018)

Co-Authored, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” Global Investigations Review (December 2017)

Quoted, “The Morning Risk Report: U.K. Enlists Behavioral Sciences to Fight Corruption,” The Wall Street Journal (December 19, 2017)

Quoted, “Employee Discipline for Anti-Corruption Issues: Due Process for a Just and Effective System (Part Three of Three),” The Anti-Corruption Report (November 29, 2017)

Quoted, “Employee Discipline for Anti-Corruption Issues: Predictability and Consistency in the Face of Inconsistent Laws (Part One of Three),” The Anti-Corruption Report (November 1, 2017)

Author, “Multinationals must be leaders, not followers, with risk management,” The Times (The Brief) (October 25, 2017)

Quoted, “China, Brazil and Russia named by healthcare companies as the riskiest markets for compliance and regulation,” International Pharmaceutical Industry (October 23, 2017)

Quoted, “Investors name UK as world’s second riskiest market for compliance and regulation,” Private Equity Wire (September 29, 2017)

Quoted, “China is ‘most riskiest market’ for compliance, regulation – study,”KYC360 (September 29, 2017)

Quoted, “UK named second riskiest market amid regulatory pressures,” Investment Week (September 28, 2017)

Quoted, “High Fines Make Working in U.K. Risky, Asset Managers Say,” Institutional Investor (September 28, 2017)

Quoted, “Finance and tech firms say UK riskiest market after China,” Financial News (September 28, 2017)

Quoted, “The DPA Learning Curve,” Commercial Dispute Resolution (August 22, 2017)

Co-author, “No Need to Overreact: Protecting Privilege in the U.S. and U.K. After the ENRC Decision,” The FCPA Report (June 21, 2017)

Quoted, “No winners in High Court's privilege ruling,” The Times (The Brief) (May 17, 2017)

Author, “Let’s Share our Expertise to Right Global Wrongs,” The Times (May 4, 2017)

Co-author, “What new DOJ guidance means for compliance,” Compliance Reporter (April 11, 2017)

Co-author, “DOJ’s New Guidance for Compliance Programs,” Harvard Law School Forum on Corporate Governance and Financial Regulation (March 19, 2017)

Co-author, “How The GDPR Will Impact Life Sciences And Health Care,” Law360 (February 21, 2017)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” Global Investigations Review’s The Practitioner’s Guide to Global Investigations (January 2017)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The US Perspective,” Global Investigations Review’s The Practitioner’s Guide to Global Investigations (January 2017)

Q&A, “In Real Estate, the Corruption Risks Can Be in the Details: Attorney,” ACAMS Money Laundering (Aug. 31, 2016)

Co-author, “Practice Note: How to handle real estate compliance risks,” The FCPA Blog (August, 25, 2016)

Co-author, “Compliance Alert: Enforcement hammer falls on real estate,” The FCPA Blog (August 23, 2016)

Co-author, “Reps & Warranties Insurance From A Compliance Perspective,” Law360 (July 28, 2016)

Co-author, “And breathe … The SFO on Privilege,” Fraud Intelligence (March 14, 2016)

Co-author, “From Corruption To AML: The Future Of Chinese Enforcement,” Law360 (March 8, 2016)

Co-author, “Standard Bank PLC: First U.K. Deferred Prosecution Agreement and Settlement with the SEC,” Ropes & Gray Alert (January 6, 2016)

Co-author, “Avoiding minefields: managing cross-border investigations,” Financier Worldwide (July 2015)

Co-author, “Mind your step! Avoiding the legal pitfalls of being an operating partner,” Operating Partner in Private Equity, Volume 2 (Private Equity International, June 2015)

Co-author, “The UK Anti-Corruption Plan: what impact will it have?,” Global Investigations Review (March 9, 2015)

Quoted, “Forceful anti-corruption enforcement making bribery more bane than boon for companies,” Association of Certified Financial Crime Specialists, (December 2014)

Co-author, “Tips for an Effective Anticorruption Monitoring Program,” Corporate Counsel (September 5, 2014)

Co-author, “Busting Bribery Post-Acquisition,” Private Equity International (August 20, 2014)

Co-author, “Minimising Corruption Risks in African Investment Opportunities,”Financier Worldwide (July 2014)

Co-author, “Medical Industries Under the Anticorruption Lens,” Corporate Counsel (April 15, 2013)

Co-author, "How To Implement Conflict Minerals Rule Requirements," Law360 (September 26, 2012)

Co-author, "The Latest FCPA Target: Private Fund Advisers," Law360 (May 11, 2012)

Author, “Global Anti-Corruption Compliance: The One Stop Shop?” Winter 2012 Criminal Justice Section Newsletter (2012)

Co-author, “A Headline Shift, Not a Priority Shift: The Government Expands Its Second Front in the War on Health Care Fraud,” Bloomberg Law Reports (December 16, 2011)

Co-author, "Facing FCPA Charges In Foreign Countries," Law360 (January 2012)

Co-author, “What Every Private Equity Professional Should Know About the Expanded Scope of Global Anticorruption Enforcement,” The Journal of Private Equity (Fall 2010)

Co-author, "The Modern Realities of the FCPA," SecuritiesLaw360 (February 19, 2009)

Presentations

Panelist, “Sexual Misconduct in the Work Place and How to Ensure Better Protection of Rights, Investigations of Issues, and Encourage Speak Up,” C5’s Women Leaders in Life Sciences Law, Amsterdam (June 2018)

Panelist, “Governance of International Sport,” MIT Sloan Sports Analytics Conference (March 2017)

Panelist, “Shopping for a business coach: Is it worth the spend?,” Women in White Collar Crime Luncheon & Panel Discussion, K&L Gates (October 2016)

Speaker, “Prevention is Better Than Cure - The Importance of Compliance Procedures Prior to an Acquisition,” Corporate M&A Summit (October 2016)

Panelist, “The role and responsibilities of monitors,” Cambridge Economic Crime Symposium (September 2016)

Speaker, “Fourth International White Collar Crime Institute,” (October 2015)

Global Investigations Review “Internal Investigations Roundtable,” (June 2015)

Presenter, “Successor Liability under the FCPA and Bribery Act,” Bloomberg Webinar (June 2015)

Moderator, “European Compliance & Ethics Institute Conflicting Compliance: When Foreign Laws are at odds with Anti-Corruption Compliance under the FCPA and UK Bribery Act,” European Compliance & Ethics Institute (March 2015)

Panelist, “How to Build Effective Internal Financial Controls to Meet Government Expectations and Minimize Exposure to Books and Records Violations,” Anti-Corruption Experts Conference (October 2013)

Panelist, “Recent Trends and Updates on Anti-Corruption, OFAC/AML and Global Financial Investigations,” NYSBA Symposium on the Challenges of Multijurisdictional Investigations and Enforcement (October 2013)

Presenter, “Foreign Corrupt Practices Act - FCPA Basics” (December 2012)

Presenter, “Anti-Corruption Laws Overview & Key Risk Areas,” Pfizer Legal Alliance Continuing Education (PLACE) (April 2012)

Presenter, “The FCPA in the Private Equity Market” (August 2010)

Amanda N. Raad

Partner

Amanda N. Raad

Partner

Contact

Practices

Industries

News

Ropes & Gray Counsels Carlyle Group in Acquisition of Significant Minority Shareholding in Cepsa

Publications

Education

Admissions / Qualifications

Qualifications

Court Admissions

Clerkships

Memberships & Affiliations

Events

Life Sciences Quarterly: Using Data to Build a More Effective Compliance Program

Experience

Disclaimer

Publications

Presentations

Publications

Presentations